Usha Chakravarthy Selected Research

Macular Degeneration (Age-Related Maculopathy)

2/2022	Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trial.
1/2022	EFFECT OF RETINAL THICKNESS VARIABILITY ON VISUAL OUTCOMES AND FLUID PERSISTENCE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Post Hoc Analysis of the HAWK and HARRIER Studies.
1/2022	Long-term Retinal Morphology and Functional Associations in Treated Neovascular Age-Related Macular Degeneration: Findings from the Inhibition of VEGF in Age-Related Choroidal Neovascularisation Trial.
1/2022	Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration: A Post Hoc Analysis of the FILLY Randomized Clinical Trial.
1/2022	Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
12/2021	Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study.
11/2021	Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD.
10/2021	Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
7/2021	Association between retinal thickness variation and visual acuity change in neovascular age-related macular degeneration.
1/2021	Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Usha Chakravarthy Research Topics

Disease

98	Macular Degeneration (Age-Related Maculopathy) 02/2022 - 03/2004
18	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2022 - 01/2002
16	Atrophy 01/2022 - 05/2014
10	Polypoidal Choroidal Vasculopathy 01/2022 - 01/2015
10	Macular Edema 11/2019 - 09/2015
9	Choroidal Neovascularization 01/2022 - 01/2007
8	Fibrosis (Cirrhosis) 01/2022 - 10/2015
6	Retinal Vein Occlusion 01/2022 - 12/2002
6	Disease Progression 01/2021 - 12/2002
4	Geographic Atrophy 01/2022 - 11/2008
4	Inflammation (Inflammations) 01/2021 - 07/2012
4	Hypertension (High Blood Pressure) 01/2021 - 06/2007
4	Cataract (Cataracts) 01/2019 - 08/2008
3	Cicatrix (Scar) 01/2022 - 01/2018
3	Neoplasms (Cancer) 11/2020 - 09/2014
3	Central Serous Chorioretinopathy 01/2020 - 05/2014
3	Eye Diseases (Eye Disease) 01/2019 - 12/2004
3	Heart Failure 10/2013 - 06/2007
2	Epiretinal Membrane (Epiretinal Membranes) 01/2020 - 01/2018
2	Vision Disorders (Hemeralopia) 09/2015 - 10/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2010 - 06/2008
1	Epstein-Barr Virus Infections 01/2022
1	Hemorrhage 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Retinal Neovascularization 05/2021
1	Refractive Errors (Refractive Error) 01/2021
1	Vitreous Hemorrhage 12/2020
1	Retinal Degeneration 11/2020
1	Diverticulitis 01/2020
1	Retinal Perforations 01/2020
1	Myocardial Infarction 01/2020
1	Ischemia 01/2019
1	Retinal Detachment (Retinal Detachments) 01/2019
1	Vitamin D Deficiency 01/2019
1	Hyperpigmentation 05/2017

Drug/Important Bio-Agent (IBA)

39	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2002
29	Retinaldehyde (Retinal)IBA 02/2022 - 01/2002
22	Ranibizumab (Lucentis)FDA Link 01/2021 - 07/2009
11	Bevacizumab (Avastin)FDA Link 01/2021 - 06/2010
7	Complement Factor H (Factor H)IBA 12/2018 - 02/2010
6	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 01/2007
6	afliberceptIBA 01/2022 - 01/2019
6	AntioxidantsIBA 08/2013 - 12/2004
5	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 01/2015
5	Retinal Pigments (Pigments, Visual)IBA 10/2021 - 05/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 06/2007
5	Complement Factor B (Factor B)IBA 12/2018 - 02/2009
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2021 - 03/2004
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019 - 08/2008
4	Carotenoids (Carotene)IBA 03/2013 - 08/2008
3	Endothelial Growth FactorsIBA 01/2021 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2016
3	Vitamin D FDA LinkGeneric 01/2019 - 01/2017
3	LuteinIBA 01/2017 - 10/2011
3	Complement C2 (Complement Component 2)IBA 09/2012 - 02/2009
3	ZeaxanthinsIBA 07/2012 - 08/2008
2	Eplerenone (Inspra)FDA LinkGeneric 01/2020 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2017
2	Fluocinolone Acetonide (Capex)FDA LinkGeneric 02/2018 - 01/2017
2	CytokinesIBA 01/2017 - 09/2014
2	Biological ProductsIBA 02/2016 - 09/2014
2	Verteporfin (Visudyne)FDA Link 05/2014 - 12/2009
2	Complement System Proteins (Complement)IBA 11/2012 - 06/2011
2	Macular PigmentIBA 07/2012 - 03/2008
2	Apolipoproteins E (ApoE)IBA 12/2011 - 06/2011
2	Vitamin A (Retinol)FDA LinkGeneric 10/2011 - 08/2008
2	Complement C3 (C3 Complement)IBA 06/2011 - 02/2010
2	HomocysteineIBA 09/2009 - 12/2005
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 09/2009 - 12/2005
1	RNA (Ribonucleic Acid)IBA 01/2022
1	pegcetacoplanIBA 01/2022
1	LipidsIBA 01/2021
1	Vascular Endothelial Growth FactorsIBA 12/2020
1	Lipocalin-2IBA 11/2020
1	PlacebosIBA 01/2020
1	SteroidsIBA 11/2019
1	Sodium-Coupled Vitamin C TransportersIBA 01/2019
1	fluocinoloneIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Fish OilsIBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	4-O-carboxymethylascochlorinIBA 01/2019
1	Acetates (Acetic Acid Esters)FDA Link 01/2019
1	Angiopoietin-2IBA 11/2017
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2017
1	hydroxide ionIBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017

Therapy/Procedure

27	Therapeutics 01/2022 - 12/2002
11	Lasers (Laser) 01/2021 - 08/2013
10	Injections 01/2022 - 01/2015
5	Photochemotherapy (Photodynamic Therapy) 10/2021 - 03/2004
5	Light Coagulation 05/2021 - 01/2017
5	Radiotherapy 01/2019 - 09/2013
4	Intravitreal Injections 01/2017 - 09/2011
3	Brachytherapy 02/2022 - 01/2016
3	Vitrectomy 12/2020 - 01/2017
2	Aftercare (After-Treatment) 05/2021 - 11/2019
2	Retreatment 12/2020 - 12/2016
1	Bariatric Surgery 01/2020
1	Traction 01/2020